| Literature DB >> 26503489 |
Andrew J Wiemer1, Rebekah R Shippy2, Ashley M Kilcollins3, Jin Li1, Chia-Hung Christine Hsiao1, Rocky J Barney4, M Lei Geng5, David F Wiemer6.
Abstract
Cell-cleavable protecting groups often enhance cellular delivery of species that are charged at physiological pH. Although several phosphonate protecting groups have achieved clinical success, it remains difficult to use these prodrugs in live cells to clarify biological mechanisms. Here, we present a strategy that uses a 7-methoxycoumarin-3-carboxylic acid ester as a fluorescent protecting group. This strategy was applied to synthesis of an (E)-4-hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP) analogue to assess cellular uptake and human Vγ9Vδ2 T cell activation. The fluorescent ester displayed low cellular toxicity (IC50 >100 μm) and strong T cell activation (EC50 =0.018 μm) relative to the unprotected anion (EC50 =23 μm). The coumarin-derived analogue allowed no-wash analysis of biological deprotection, which revealed rapid internalization of the prodrug. These results demonstrate that fluorescent groups can be applied both as functional drug delivery tools and useful biological probes of drug uptake.Entities:
Keywords: antigens; butyrophilin; coumarin; phosphorus; prodrugs
Mesh:
Substances:
Year: 2015 PMID: 26503489 PMCID: PMC4746711 DOI: 10.1002/cbic.201500484
Source DB: PubMed Journal: Chembiochem ISSN: 1439-4227 Impact factor: 3.164